These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 22229922)

  • 41. [News in the treatment of Dupuytren's disease: from surgery to collagenase's injection].
    Cuylits N
    Rev Med Brux; 2013 Sep; 34(4):283-6. PubMed ID: 24195241
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Complications after treating Dupuytren's disease. A systematic literature review.
    Krefter C; Marks M; Hensler S; Herren DB; Calcagni M
    Hand Surg Rehabil; 2017 Oct; 36(5):322-329. PubMed ID: 28917432
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Dupuytren Disease Management Trends: A Survey of Hand Surgeons.
    Carr L; Michelotti B; Brgoch M; Hauck R; Ingraham J
    Hand (N Y); 2020 Jan; 15(1):97-102. PubMed ID: 30043624
    [No Abstract]   [Full Text] [Related]  

  • 44. Percutaneous needle fasciotomy in Dupuytren's contracture: is it a viable technique?
    Pereira A; Massada M; Sousa R; Silva C; Trigueiros M; Lemos R
    Acta Orthop Belg; 2012 Feb; 78(1):30-4. PubMed ID: 22523924
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Minimally invasive partial fasciectomy for Dupuytren contractures.
    Gelman SE; Schlenker R; Jacoby SM; Shin EK; Culp RW
    Tech Hand Up Extrem Surg; 2012 Dec; 16(4):184-6. PubMed ID: 23160547
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Dupuytren's disease - what's new: a review.
    Żyluk A
    Pol Przegl Chir; 2022 Oct; 95(6):53-61. PubMed ID: 38058165
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Needle aponeurotomy: a treatment alternative for Dupuytren's disease.
    Van Demark RE; Van Demark RE
    S D Med; 2011 Nov; 64(11):411, 413, 415 passim. PubMed ID: 22164819
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Dupuytren's disease: diagnosis and treatment.
    Trojian TH; Chu SM
    Am Fam Physician; 2007 Jul; 76(1):86-9. PubMed ID: 17668844
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A comparison of the direct outcomes of percutaneous needle fasciotomy and limited fasciectomy for Dupuytren's disease: a 6-week follow-up study.
    van Rijssen AL; Gerbrandy FS; Ter Linden H; Klip H; Werker PM
    J Hand Surg Am; 2006; 31(5):717-25. PubMed ID: 16713831
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Needle fasciotomy for Dupuytren's disease: an Australian perspective.
    Lee MV; Hunter-Smith D
    ANZ J Surg; 2009 Nov; 79(11):776-8. PubMed ID: 20078523
    [No Abstract]   [Full Text] [Related]  

  • 51. Impact on costs of switching one-ray aponeurectomy to percutaneous needle aponeurotomy in Dupuytren's disease: A model analysis.
    Maravic M; Beaudreuil J
    Joint Bone Spine; 2015 Jul; 82(4):264-6. PubMed ID: 25857217
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Treatment of Dupuytren's contracture by means of injectable collagenase: first clinical experiences].
    Spanholtz TA; Holzbach T; Wallmichrath J; Pototschnig A; Deglmann C; Frick A; Giunta RE
    Handchir Mikrochir Plast Chir; 2011 Oct; 43(5):275-80. PubMed ID: 21935844
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Advances in the understanding of the aetiology of Dupuytren's disease.
    Picardo NE; Khan WS
    Surgeon; 2012 Jun; 10(3):151-8. PubMed ID: 22297148
    [TBL] [Abstract][Full Text] [Related]  

  • 54. CURRENT TREATMENT OPTIONS OF DUPUYTREN´S DISEASE.
    Kníže J; Miletín J; Nejedlý A; Chorvát M; Novotná K; Tichá P; Fibír A; Sukop A; Knížetová A
    Acta Chir Plast; 2018; 59(3-4):142-148. PubMed ID: 29651852
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Breaking the rules: Dupuytren's disease under Skoog's fibres.
    Munson CF; Davidson D; Lohana P
    Hand Surg; 2013; 18(2):255-6. PubMed ID: 24164133
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Minimally Invasive Options in Dupuytren's Contracture: Aponeurotomy, Enzymes, Stretching, and Fat Grafting.
    McInerney NM; Clover AJ
    Plast Reconstr Surg; 2015 Jun; 135(6):1066e-1067e. PubMed ID: 25724046
    [No Abstract]   [Full Text] [Related]  

  • 57. Avoidance of recurrence of CRPS Type 1 in individuals requiring further surgery for Dupuytren's contracture.
    Van Dam H; Elliot D
    J Plast Reconstr Aesthet Surg; 2014 Jun; 67(6):878-9. PubMed ID: 24529691
    [No Abstract]   [Full Text] [Related]  

  • 58. Patient's perspective of treatment in Dupuytren's Disease: collagenase versus limited fasciectomy.
    Beecher SM; Wilkinson JE; Cuggy C; O'Shaughnessy M
    J Hand Surg Eur Vol; 2022 Dec; 47(11):1172-1174. PubMed ID: 35469501
    [No Abstract]   [Full Text] [Related]  

  • 59. Hand therapy or not following collagenase treatment for Dupuytren's contracture? Protocol for a randomised controlled trial.
    Aglen T; Matre KH; Lind C; Selles RW; Aßmus J; Taule T
    BMC Musculoskelet Disord; 2019 Aug; 20(1):387. PubMed ID: 31455312
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Surgical treatment of a case of congenital Dupuytren's disease.
    Zheng HY; Liu J
    J Plast Reconstr Aesthet Surg; 2013 Mar; 66(3):e76-8. PubMed ID: 23238117
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.